Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Nucore Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Nucore Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 265 · Grade C

Nucore Health

Visit Nucore Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Nucore Health a bad call — it's best for readers who want to compare injection and compounded oral routes and can confirm the actual prescription, recurring term and refund status. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
82
Track Record
88
73
CoreAge RxBrief Score 94 · 65Nucore Health

Price, coverage & the tracker

CoreAge RxNucore Health
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Injection advertised from $179/month

Compounded oral option from $209/month; final formulation, supplied quantity, term and total unconfirmed.

No membership fee advertised; recurring programs still require seventy-two-hour cancellation notice.

Full price details

Compounded semaglutide offered; complete selected-plan quote unknown; injection advertised from $179/month and compounded oral option from $209/month; final formulation and price require review

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Injection advertised from $269/month

Compounded treatment; final supplied quantity, recurring term and complete quote unconfirmed.

Refund eligibility can end when pharmacy ordering or processing begins, before shipment.

Full price details

Compounded tirzepatide offered; complete selected-plan quote unknown; injection advertised from $269/month; supplied quantity, term and final price require review

CoverageUS only; restrictions by state, confirmed at intakeAvailability varies; current medication-specific state list and assigned clinician/pharmacy eligibility require confirmation
Brand-name accessNot confirmedReviewed GLP-1 options are compounded; current branded fulfillment was not established.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Nucore Health: Injection starting advertisements: $179 semaglutide/$269 tirzepatide; compounded oral semaglutide $209. Final selected supply, price and recurring term unconfirmed.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.